Javascript must be enabled for the correct page display
Skip to Content
navigation opener
Events

2026 BPI Boston Keynote Presentation: Lessons from Global Leadership in CMC, Technology Transfer, and Manufacturing

September 24, 2026
BPI Boston 2026
Keynote Presentation
Hynes Convention Center, Boston, USA
11:30 am ET
30 minute live presentation

Lessons from Global Leadership in CMC, Technology Transfer, and Manufacturing
Tom Gervais
Vice President, Manufacturing, Rockville, MD

Abstract
Developing and establishing robust processes, analytical methods, and supply chains for the manufacture of biologics requires clarity, coordination, and commitment. Alignment and integration can be challenging if inherent assumptions and communication norms are not readily apparent to all individuals working on a given project. This presentation explores some of the dynamics and interactions amongst teams, systems, cultures, and technologies that influence CMC, technology transfer, and manufacturing. Considerations for emerging technologies and communication tools will also be discussed.

Presenter Bio
Tom is currently the Vice President, Manufacturing at Bora Biologics where he is responsible for developing manufacturing strategy and leading operations for clinical and commercial production. Prior to joining Bora Biologics, he was Vice President, Manufacturing for MacroGenics, and held leadership roles in Process Development, Manufacturing Sciences and Technology, and Process Life Cycle Management at Centocor/Johnson & Johnson, Bristol-Myers Squibb, Samsung Biologics, and NexImmune. Tom earned his Ph.D. in Chemical Engineering from the University of Virginia and his B.S. in Chemical Engineering from The Pennsylvania State University.

BPI Biotech Week Boston Website

Filter

Bora Biologics

the logical choice

Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.

Partner with us

Client-Centric

100% commitment to supporting your success

We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

Experience

15+ years developing & manufacturing biologics

We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

Expertise

Over 200 seasoned scientists & regulatory professionals

Our team exudes deep knowledge and specialized skills. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

Commercial-Ready

2 US FDA registered GMP manufacturing facilities

We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

Allied

access to global CDMO resources

Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.